COMPOSITIONS BASED ON RADIATION-CURABLE FUNCTIONALISED SILICONES AND ANTI-ADHESIVE COATINGS OBTAINED FROM SAME

Details for Australian Patent Application No. 2002314284 (hide)

Owner Lucile, Gambut-Gabrel RHODIA CHIMIE

Inventors SCIOLLA, Michel; FRANCES, JeanMarc; MIGNANI, Gerard; HANTIN, Veronique; GAMBUT-GAREL, Lucile

Pub. Number AU-A-2002314284

PCT Number PCT/FR02/01852

PCT Pub. Number WO2002/096998

Priority 01/07235 01.06.01 FR

Filing date 31 May 2002

Wipo publication date 9 December 2002

International Classifications

C08K 005/55 Use of organic ingredients

C09J 007/04 Adhesives in the form of films or foils - on paper or textile fabric

C09J 007/02 Adhesives in the form of films or foils - on carriers

C09D 183/06 Coating compositions based on macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon, with or without sulfur, nitrogen, oxygen, or carbon only - containing silicon bound to oxygen-containing groups

Event Publications

2 January 2003 Complete Application Filed

  Priority application(s): 01/07235 01.06.01 FR

8 May 2003 Application Open to Public Inspection

  Published as AU-A-2002314284

11 March 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002314285-BACK-PROJECTION SCREEN

2002314283-POLYPEPTIDES REACTING WITH HCV-INFECTED PATIENTS' ANTIBODIES AND USES